Disaggregated Networking Solution Optimized for Ethernet-based AI Data Center Fabrics on OCP-Accepted Hardware from Edgecore and UfiSpace; IP Infusion Speaking with HYPER SCALERS on AI and Open Networking at OCP APAC Summit
Santa Clara, CA – July 16, 2025 – IP Infusion, a global leader in open networking solutions, is excited to announce its participation in the OCP APAC Summit 2025 in Taipei, Taiwan, Aug. 5-6. IP Infusion is speaking and exhibiting with HYPER SCALERS at this summit on the topic of AI infrastructure and open networking. IP Infusion will demonstrate its OcNOS Data Center networking operating system, which is optimized for Ethernet-based AI data center fabrics, running on open networking hardware from ecosystem partners Edgecore und UfiSpace.
OcNOS-DC delivers performance, scalability, and flexibility for AI workloads, enabling data center operators to build high-performance, disaggregated networks that reduce total cost of ownership (TCO) while accelerating innovation. Attendees can visit IP Infusion's booth to experience demonstrations of OcNOS-DC on Edgecore and UfiSpace's OCP-accepted hardware, showcasing seamless interoperability and advanced features tailored for next-generation data center fabrics.
"IP Infusion's OcNOS Data Center products set a new standard for AI-driven data centers, combining carrier-grade reliability with the agility of open networking," said Kiyo Oishi, CEO of IP Infusion. "We're thrilled to partner with HYPER SCALERS, Edgecore, and UfiSpace to demonstrate our network disaggregation solution at the OCP APAC Summit, empowering operators to meet the demands of modern AI workloads."
Mingshou Liu, President of Edgecore Networks, said: "Edgecore's open networking platforms, paired with IP Infusion's OcNOS Data Center software, deliver a robust and scalable solution for AI data centers. Our collaboration at this OCP event highlights our strong partnership and commitment to driving innovation and flexibility in disaggregated networking."
Vincent Ho, CEO of UfiSpace, said: "The integration of UfiSpace's high-performance, white box platforms with OcNOS Data Center empowers service providers and data center operators to deploy scalable, efficient AI fabrics. We're excited to showcase this powerful collaboration and advance open networking across the region."
IP Infusion invites attendees to visit its booth to explore how OcNOS Data Center, combined with Edgecore and UfiSpace hardware, is redefining data center networking for AI applications. IP Infusion's VP Sales APAC Frederik Hoogenboom is speaking at the OCP APAC Summit 2025 on Aug. 5 on the topic "Unlocking AI Infrastructure: Open Networking with IP Infusion and HYPER SCALERS."
To schedule a meeting or demo, visit OCP APAC Summit 2025: https://www.ipinfusion.com/ocp-apac-summit-2025/
-end-
Pressekontakt
Katherine Verducci, 1903 PR
kverducci@1903pr.com
408.429.5779
Über IP Infusion
IP Infusion ist ein führender Anbieter von Open-Networking-Software und liefert OcNOS, ein Carrier-Grade-Netzwerkbetriebssystem für Service Provider, Rechenzentren und AI-Fabric-Netze. Mit 26+ Jahren Netzwerkerfahrung und 600+ Operatoren weltweit ermöglicht IP Infusion offene, herstellerübergreifende, kosteneffiziente und flexible Netzwerkinfrastruktur auf validierter offener Hardware von Partnern wie Edgecore Networks, UfiSpace und Celestica. IP Infusion ist eine hundertprozentige Tochtergesellschaft der ACCESS CO., LTD. (Tokyo Stock Exchange: 4813).
Pressekontakt
For press inquiries, analyst briefings, or media materials, please unser Team kontaktieren or email pr@ipinfusion.com.
Zukunftsgerichtete Aussagen
Diese Mitteilung kann zukunftsgerichtete Aussagen zu Produkten, Technologien und Plänen von IP Infusion enthalten. Zukunftsgerichtete Aussagen beruhen auf den zum Veröffentlichungsdatum verfügbaren Informationen und sind mit Risiken und Unsicherheiten verbunden. Die tatsächlichen Ergebnisse können abweichen. Produktpläne, Funktionen, Release-Termine und Verfügbarkeit können sich ohne Vorankündigung ändern und stellen keine Zusage, kein Versprechen und keine rechtliche Verpflichtung dar. IP Infusion übernimmt keine Verpflichtung, zukunftsgerichtete Aussagen zu aktualisieren.